These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24839139)

  • 1. Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide.
    Dhar A; Mallick S; Ghosh P; Maiti A; Ahmed I; Bhattacharya S; Mandal T; Manna A; Roy K; Singh S; Nayak DK; Wilder PT; Markowitz J; Weber D; Ghosh MK; Chattopadhyay S; Guha R; Konar A; Bandyopadhyay S; Roy S
    Biopolymers; 2014 Jul; 102(4):344-58. PubMed ID: 24839139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.
    Inman KG; Yang R; Rustandi RR; Miller KE; Baldisseri DM; Weber DJ
    J Mol Biol; 2002 Dec; 324(5):1003-14. PubMed ID: 12470955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.
    Charpentier TH; Thompson LE; Liriano MA; Varney KM; Wilder PT; Pozharski E; Toth EA; Weber DJ
    J Mol Biol; 2010 Mar; 396(5):1227-43. PubMed ID: 20053360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B.
    Wafer LN; Streicher WW; McCallum SA; Makhatadze GI
    Biochemistry; 2012 Sep; 51(36):7189-201. PubMed ID: 22913742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
    Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
    Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.
    Hearst SM; Walker LR; Shao Q; Lopez M; Raucher D; Vig PJ
    Neuroscience; 2011 Dec; 197():369-80. PubMed ID: 21958864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering S100B Allosteric Signaling: The Role of a Peptide Target, TRTK-12, as an Ensemble Modulator.
    Samanta R; Zhuang X; Varney KM; Weber DJ; Matysiak S
    J Chem Inf Model; 2024 Apr; 64(8):3477-3487. PubMed ID: 38605537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex.
    McClintock KA; Shaw GS
    J Biol Chem; 2003 Feb; 278(8):6251-7. PubMed ID: 12480931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.
    Lin J; Yang Q; Wilder PT; Carrier F; Weber DJ
    J Biol Chem; 2010 Aug; 285(35):27487-27498. PubMed ID: 20587415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
    Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
    Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization.
    Garbuglia M; Verzini M; Rustandi RR; Osterloh D; Weber DJ; Gerke V; Donato R
    Biochem Biophys Res Commun; 1999 Jan; 254(1):36-41. PubMed ID: 9920729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and thermodynamic characterization of the recognition of the S100-binding peptides TRTK12 and p53 by calmodulin.
    Wafer LN; Tzul FO; Pandharipande PP; McCallum SA; Makhatadze GI
    Protein Sci; 2014 Sep; 23(9):1247-61. PubMed ID: 24947426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the binding site on S100B protein for the actin capping protein CapZ.
    Kilby PM; Van Eldik LJ; Roberts GC
    Protein Sci; 1997 Dec; 6(12):2494-503. PubMed ID: 9416599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
    Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
    Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of two intrinsically disordered peptides to a multi-specific protein: a combined Monte Carlo and molecular dynamics study.
    Staneva I; Huang Y; Liu Z; Wallin S
    PLoS Comput Biol; 2012; 8(9):e1002682. PubMed ID: 23028280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aib-based peptide backbone as scaffolds for helical peptide mimics.
    Banerjee R; Basu G; Chène P; Roy S
    J Pept Res; 2002 Aug; 60(2):88-94. PubMed ID: 12102721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
    Rustandi RR; Baldisseri DM; Weber DJ
    Nat Struct Biol; 2000 Jul; 7(7):570-4. PubMed ID: 10876243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.
    Do TN; Rosal RV; Drew L; Raffo AJ; Michl J; Pincus MR; Friedman FK; Petrylak DP; Cassai N; Szmulewicz J; Sidhu G; Fine RL; Brandt-Rauf PW
    Oncogene; 2003 Mar; 22(10):1431-44. PubMed ID: 12629507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminus and linker region of S100B exert dual control on protein-protein interactions with TRTK-12.
    McClintock KA; Van Eldik LJ; Shaw GS
    Biochemistry; 2002 Apr; 41(17):5421-8. PubMed ID: 11969402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
    Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
    Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.